WO1996015768A1 - Oral compositions - Google Patents

Oral compositions Download PDF

Info

Publication number
WO1996015768A1
WO1996015768A1 PCT/US1995/014013 US9514013W WO9615768A1 WO 1996015768 A1 WO1996015768 A1 WO 1996015768A1 US 9514013 W US9514013 W US 9514013W WO 9615768 A1 WO9615768 A1 WO 9615768A1
Authority
WO
WIPO (PCT)
Prior art keywords
copper
monophosphate
oral composition
group
composition according
Prior art date
Application number
PCT/US1995/014013
Other languages
French (fr)
Inventor
Lowell Alan Sanker
James Grigg Upson
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to AU40160/95A priority Critical patent/AU4016095A/en
Publication of WO1996015768A1 publication Critical patent/WO1996015768A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925Markers, e.g. radio-opaque or breast lesions markers ultrasonic
    • A61B2090/3929Active markers

Definitions

  • the present invention relates to oral compositions which provide antiplaque and antigingivitis benefits as well as being effective against other anaerobic infections of the mouth.
  • Periodontal disease affects the periodontium, which is the investing and supporting tissue surrounding a tooth (i.e., the periodontal ligament, the gingiva, and the alveolar bone). Gingivitis and periodontitis are in ⁇ flammatory disorders of the gingiva and the periodontal ligament, respectively. Gingivosis and periodontosis are more severe conditions involving degenerative disorders of the tissue. Combinations of inflammatory and degenerative conditions are termed periodontitis complex.
  • Periodontal disease is a major cause of tooth loss in adults. Tooth loss from periodontal disease is a significant problem beginning at age 35, but even by age 15 it is estimated that about 4 out of 5 persons already have gingivitis and 4 out of 10 have periodontitis.
  • compositions of the present invention which contain copper compounds along with certain phosphate derivatives, provide improved tasting, antiplaque/antigingivitis compositions. Additionally, the present inventors have found that incorporating such phosphate derivatives provides improved actual and/or perceived efficacy of the resultant compositions. Further, these phosphate derivatives result in oral compositions providing a delayed flavor onset.
  • an object of the present invention is to provide improved copper containing, oral compositions comprising a combination of phosphate derivatives.
  • Another object of the present invention is to provide good-tasting oral com- positions effective in preventing and treating diseases of the oral cavity and prevent ⁇ ing mouth odor.
  • a further object of the present invention is to provide methods for preventing and treating diseases of the oral cavity.
  • the present invention relates to oral compositions, comprising. a) from about 0.001% to about 25% of at least one phosphate derivative having the structure:
  • R is selected from the group consisting of a coolant compo ⁇ nent, a sweetener component, and a flavorant component; wherein R' and R" are independently selected from the group consist ⁇ ing of R, an adherent component, M + , M "1" " , C + , and hydrogen; wherein X, X', X" are independently selected from the group consist ⁇ ing of oxygen, nitrogen, and sulfur; wherein n is an integer from 1 to 3; b) a safe and effective amount of a copper ion source; and c) a pharmaceutically acceptable oral carrier.
  • the present invention also relates to the above compositions further compris ⁇ ing a flavoring agent.
  • the present invention further relates to methods of treating or preventing diseases of the oral cavity.
  • oral composition means a product which in the ordinary course of usage is not intentionally swallowed for purposes of systemic administra ⁇ tion of particular therapeutic agents, but is rather retained in the oral cavity for a time sufficient to contact substantially all of the dental surfaces and/or oral tissues for purposes of oral activity.
  • safety and effective amount means sufficient amount of material to provide the desired benefit while being safe to the hard and soft tissues of the oral cavity.
  • pharmaceutically acceptable oral carrier means a suitable vehicle which can be used to apply the present compositions to the oral cavity in a safe and effective manner. All levels and ratios are by weight of the total composition, unless otherwise indicated. Additionally, all measurements are made at 25°C unless otherwise speci ⁇ fied.
  • compositions of the present invention contain one or more phosphate derivatives. These compounds may be formulated by phosphorylating at least one coolant, sweetener or flavorant component. These compounds also include linking at least one coolant, sweetener or flavorant component to an adherent component via a phosphate bridge. In addition, pyrophosphate and triphosphate groupings may be substituted for the phosphate group. Coolant, flavorant, or adherent components may also be linked to phosphorous via two functional groups or attachment sites. Furthermore, the phosphate derivatives described above may be bound via Coulom- bic interaction with charged compounds or materials, including polymers The present compositions may deliver the desired coolant, flavorant and/or sweetener qualities through the action of the phosphate derivative itself.
  • the com ⁇ positions may also provide a sustained or delayed effect since release of the coolant, flavorant and/or sweetener component from the molecule does not occur until cleavage of the phosphate from the coolant, flavorant and/or sweetener by phosph- atase enzymes. Without being limited by theory, it is believed that this sustained or delayed release profile provides improved actual and/or perceived efficacy.
  • the phosphatase enzymes may include, but are not limited to, acidic, basic, or pyro- phosphatases.
  • coolant component refers to coolant compounds having a hydroxy, amino, or thiol functionality which is capable of forming an ester, amido, or thioester linkage with a phosphorus(V) atom.
  • Preferred coolant compo ⁇ nents are selected from the group consisting of menthol, 3-l-menthoxypropane-l,2- diol (TK-10 supplied by Takasago Perfumery Co., Ltd., Tokyo, Japan), menthone glycerol acetal ("MGA"), N-ethyl-p-menthane-3-carboxamide (WS-3 supplied by Sterling Organics), N,2,3-trimethyl-2-isopropylbutanamide (WS-23 supplied by SCM Glidco Organics) or menthyl lactate.
  • TK-10 3-l-menthoxypropane-l,2- diol
  • MCA menthone glycerol acetal
  • WS-3 supplied by Sterling Organics
  • WS-23 supplied by SCM Glidco Organics
  • menthyl lactate menthyl lactate
  • flavorant component refers to flavorant chemicals having a hydroxy, amino, or thiol functionality which is capable of forming either an ester, amido, or thioester linkage with a phosphorus(V) atom.
  • Flavorant chemicals suitable for use in the present invention include hexanol, octanol, decanol, geranolol, ethyl maltol, para-hydroxy phenylbutanone, phenyl ethyl alcohol, thymol, eugenol, eucalyptol, methyl salicylate, ethyl vanillin, vanillin, cinnamaldehyde glycerol acetal (“CGA”), or linalool.
  • suitable chemical flavorants are described in S. Arctander, Perfume and Flavor Chemicals. (1969) and Allure Publishing Corpo ⁇ ration's Flavor and Fragrance Materials.
  • sweetener component refers to sweetener com ⁇ pounds having a hydroxy, amino, or thiol functionality which is capable of forming either an ester, amido, or thioester linkage with a phosphorus(V) atom.
  • Preferred -sweetener components are saccharin, xylitol, mannitol, sorbitol, acesulfame K, aspartame, and neohesperidin dihydrochalcone
  • adherent component refers to either monomers, oligomers, or polymers having hydroxy, amino, or thiol functionalities which are capable of forming either ester amido, or thioester linkages with phosphorus(V) atoms.
  • the monomers, oligomers, or polymers may also possess additional hydroxy, amino, or thiol groups which may either remain unsubstituted or be linked via ester amido, or thioester linkages to a phosphorus(V) atom which is also attached to a coolant, flavor, or active portion.
  • Preferred compounds are selected from the group consisting of C12-C18 diacyl glycerol, partially hydrolyzed vinyl acetate/ethylene copolymer, cellulose, chitin, glucosamine, silica gel, glycerol, and lower alkyl vinyl ether-maleic acids.
  • M+ and M++ refer to physiologically relevant metal cations.
  • physiologically relevant metal cations refers to metal cations that are significant to the organic or bodily processes of a human or lower animal.
  • Preferred “M+” cations are sodium and potassium.
  • Pre ⁇ ferred “M++” cations are calcium, zinc, magnesium, manganese, copper, and stan- founded.
  • C+ refers to a cation.
  • a cation as used herein refers to cations that contain positively charged nitrogen, phosphorus, oxygen, or sul ⁇ fur atoms. Such cations may contain more than one positively-charged site and in the case of oligomers or polymers containing nitrogen, phosphorus, oxygen, or sulfur at ⁇ oms, many positively-charged centers may exist.
  • Preferred cations include ammo ⁇ nium, protonated amines such as protonated glucosamine, and partially or fully protonated amine-containing polymers such as protonated chitosan.
  • the phosphate derivatives of this invention are represented by the following formula.
  • R is selected from the group consisting of a coolant component, a sweetener component, and a flavorant component;
  • R' and R" are independently selected from the group consisting of R, an adherent component, M+, M++, C+, and hydrogen;
  • X, X", and X" are independently selected from the group consisting of oxy ⁇ gen, nitrogen, and sulfur; and n is an integer from 1 to 3.
  • R' may equal R", preferably wherein R' and R" are selected from the group consisting of calcium, zinc, magnesium, manganese, copper and stannous.
  • Preferred phosphate derivatives have the formula:
  • R is selected from the group consisting of menthol, TK-10, WS-3, WS-23, MGA, methyl salicylate, acesulfame K, aspartame, saccharin, mannitol, sorbitol, neohesperidin dihydrochalcone, eugenol, vanillin, thymol, CGA, and linalool;
  • R' and R" are independently selected from the group consisting of R, C12- C 18 diacyl glycerol, partially hydrolyzed vinyl acetate-ethylene co-polymer, cellulose, chitin, glucosamine, silica gel, glycerol, lower alkyl vinyl ether-maleic acids, sodium, potassium, calcium, zinc, magnesium, manganese, copper and stannous, ammonium, protonated amines, partially or fully protonated amine-containing polymers, and hydrogen;
  • X, X', and X" are independently selected from the group consisting of oxy ⁇ gen, nitrogen, and sulfur; and n is and integer from 1 to 3.
  • R' may equal R", preferably wherein R' and R" are independently selected from the group consisting of calcium, zinc, magnesium, manganese, copper and stannous.
  • phosphate derivatives are menthyl monophosphate, eugenyl monophosphate, thymyl monophosphate, vanillyl monophosphate.
  • the phosphate derivatives are used in the present invention at levels of from about 0.001% to about 25%, preferably from about 0.01% to about 15%, and most preferably from about 0.10% to about 5% by weight of the composition. Mixtures of the above described phosphate derivatives may also be used, improving the phosphate derivative activity. Copper ion source
  • Another essential component of the present invention is a compound providing a readily available source of copper ions.
  • Compounds useful as such a copper ion source may be present in the compositions of the present invention at levels between about 1 and about 8000 ppm of copper ions. The preferred range being from about 25 to about 6000 ppm, with the most preferred range being from about 50 to about 4000 ppm.
  • the preferred levels are from about 50 to about 8000 ppm, more preferably from about 100 to about 6000 ppm, and most preferably from about 100 to about 4000 ppm.
  • For rinses the levels are preferably from about 25 to about 1000 ppm, more preferably from about 50 to about 750 ppm, and most preferably from about 50 to about 500 ppm.
  • levels as low as about 1 ppm copper are effective.
  • Suitable inorganic copper ion sources include copper chloride, CuCl , and the dihydrate thereof; copper fluoride, CuF and the dihydrate thereof; copper fluorosili- cate, CuSiF , and the hexahydrate thereof; copper sulphate, CuSO , and the pen- 6 4 tahydrate thereof; copper nitrate and the tri- and hexa-hydrates thereof; and also less popular copper salts, such as copper bromide, CuBr ; copper metaborate,
  • Cu(BO ) copper bromate, Cu(BrO ) ; copper chlorate; Cu(ClO ) 6-H O; copper lodate, Cu(IO ) , copper fluorophosphate, CuPO F, or mixtures thereof.
  • Preferred copper salts of organic acids include copper acetate, copper for- miate, copper benzoate, copper citrate, copper tartrate, copper lactate, copper malate, copper lysinate, copper mandelate, copper sorbate, copper pantothenate, copper gluconate, copper phytate, copper glycerophosphate, copper cinnamate, copper butyrate, copper propionate, copper laurate, copper oxalate, copper salicy ⁇ late, copper glycinate, copper bis-glycinate or mixtures thereof. Mixtures of inor- ganic or organic salts may also be used.
  • a preferred copper ion source for the compositions of the present invention is copper bis-glycinate. Copper bis-glycinate is further described in U.S. Patent Appli ⁇ cation Serial Number 08/096,535 to Mobley et al., filed July 22, 1993, herein incor ⁇ porated by reference.
  • Pharmaceutically Acceptable Carrier
  • the carrier for the active ingredient(s) herein can be any composition suitable for use in the oral cavity.
  • Such compositions include toothpastes, mouthrinses, liquid dentifrices, lozenges, chewing gums or other vehicles suitable for use in the oral cavity. Toothpaste and mouthrinses are the preferred systems.
  • the abrasive polishing material contemplated for use in the toothpaste com ⁇ positions of the present invention can be any material which does not excessively abrade dentin.
  • silicas including gels and precipitates, calcium carbonate, dicalcium orthophosphate dihydrate, calcium pyrophosphate, tricalcium phosphate, calcium polymetaphosphate, insoluble sodium polymetaphos- phate, hydrated alumina, and resinous abrasive materials such as particulate conden ⁇ sation products of urea and formaldehyde, and others such as disclosed by Cooley et al. in U.S. Patent 3.070.510. December 25, 1962, inco ⁇ orated herein by reference. Mixtures of abrasives may also be used.
  • Silica dental abrasives of various types, can provide the unique benefits of exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentin. For these reasons they are preferred for use herein.
  • the silica abrasive can be precipitated silica or silica gels such as the silica xerogels described in Pader et al., U.S. Patent 3.538.230. issued March 2, 1970 and DiGiulio, U.S. Patent 3.862.307.
  • silica xerogels marketed under the tradename "Syloid" by W. R. Grace & Company, Davison Chemical Division.
  • Preferred precipitated silica materials include those marketed by the J. M. Huber Co ⁇ oration under the tradename, "Zeodent", particularly the silicas carrying the designation "Zeodent 119" and "Zeodent 128".
  • Zeodent particularly the silicas carrying the designation "Zeodent 119" and "Zeodent 128.
  • the abrasive in the toothpaste compositions described herein is present at a level of from about 6% to 70%, preferably from about 15% to about 25%.
  • Flavoring agents can also be added to toothpaste compositions.
  • Suitable fla- voring agents include oil of wintergreen, oil of peppermint, oil of spearmint, oil of cloves or mixtures thereof.
  • Additional flavoring agents useful in the compositions of the present invention apart from those mentioned as components of the phosphate derivatives include anise, cassia, anethole, dihydroanethole, ethyl maltol, estragole, menthol, para-hydroxy phenylbutanone, phenyl ethyl alcohol, sweet birch, thymol, eugenol, eucalyptol, cinnamic aldehyde, menthone, alpha-ionone, ethyl vanillin, vanillin, limonene, isoamylacetate, benzaldehyde, ethylbutyrate, cinnamaldehyde glycerol acetal (“CGA”), lin
  • flavoring agents which can be used include aspartame. acesulfame K, saccharin, dextrose, levulose, xylitol, mannitol and sodium cyclamate. Flavoring and sweetening agents are generally used in toothpastes at levels of from about 0.005% to about 2% by weight.
  • Toothpaste compositions can also contain emulsifying agents.
  • Suitable emulsi ⁇ fying agents are those which are reasonably stable and foam at a wide pH range, including non-soap anionic, nonionic, cationic, zwitterionic and amphoteric organic synthetic detergents. Many of these suitable agents are disclosed by Gieske et al. in U.S. Patent 4.051.234. September 27, 1977, inco ⁇ orated herein by reference.
  • the emulsifying agents are present at a level of from about 0.5% to about 10.0%.
  • Water is also present in the toothpastes of this invention.
  • Water employed in the preparation of commercially suitable toothpastes should preferably be deionized and free of organic impurities.
  • Water generally comprises from about 10% to 50%, preferably from about 30% to 50%, by weight of the toothpaste compositions herein. These amounts of water include the free water which is added plus that which is introduced with other materials such as with sorbitol.
  • thickening agents are carboxyvinyl polymers, carrageenan, hydroxyethyl cellulose and water soluble salts of cellulose ethers such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxy ⁇ ethyl cellulose.
  • Natural gums such as gum karaya, xanthan gum, gum arabic, and gum tragacanth can also be used.
  • Colloidal magnesium aluminum silicate or finely divided silica can be used as part of the thickening agent to further improve texture.
  • Thickening agents in an amount from 0.2% to 5.0% by weight of the total composi ⁇ tion can be used.
  • humectant material in a toothpaste to keep it from hardening.
  • Suitable humectants include glycerin, sorbitol, and other edible polyhydric alcohols at a level of from about 10% to about 70%.
  • Mouthwashes generally comprise from about 20: 1 to about 2: 1 of a water/ethyl alcohol solution or be alcohol free and, preferably, other ingredients such as flavors, sweeteners, humectants and sudsing agents such as those mentioned above for dentifrices.
  • the humectants, such as glycerin and sorbitol give a moist feel to the mouth.
  • the mouthwashes of the invention comprise 0% to 30% (preferably 0% to 5%) ethyl alcohol, 0% to 30% (preferably 5% to 30%) of a hu ectant, 0% to 2% (preferably 0.01% to 1.0%) emulsifying agents, 0% to 0.5% (preferably 0.005% to 0.10%) sweetening agent such as saccharin, 0% to 0.6% (preferably 0.03% to 0.3%) flavor- ing agent, and the balance water.
  • sweetening agent such as saccharin, 0% to 0.6% (preferably 0.03% to 0.3%) flavor- ing agent
  • Other optional components described herein earlier for use in toothpaste products are also useful in the mouthwash composition.
  • Suitable lozenge and chewing gum components are disclosed in U.S. Patent 4.083.955. April 11, 1978 to Grabenstetter, inco ⁇ orated herein by reference in its entirety.
  • An additional optional ingredient for use in the compositions of the present invention is a soluble fluoride ion source.
  • soluble fluoride ion source include sodium fluoride, stannous fluoride, sodium monofluorophosphate and are used in amounts sufficient to provide from about 10 to about 3500 ppm F .
  • non-cationic water insoluble agents such as triclosan.
  • triclosan Such materials are disclosed in U. S. 4.022.889. to Vinson et al., inco ⁇ o ⁇ rated herein by reference in its entirety.
  • the pH of the present compositions and/or the pH in the mouth can be any pH which is safe for the mouth's hard and soft tissues.
  • Such pH*s are generally from about 4.0 to about 9.5, preferably from about 4.5 to about 8.5. Buffers may be added to maintain this pH.
  • Such buffers should, however, not complex with copper ions in a manner such that the functioning of the compositions of this invention is hindered.
  • compositions are used in a conventional manner wherein the amounts of product are what users generally use.
  • Sorbitol Solution (70% Aqueous) 10.25 — — 8.85 7.25
  • Thymyl Monophosphate 0.40 0.20 0.12 —
  • Sorbitol Solution (70% Aqueous) 54.27 46.86 52.45 58.48 47.25
  • Vanillyl Monophosphate 0.85 — 1.00 0.80
  • Thymyl Monophosphate 0.90 —

Abstract

Disclosed are oral compositions such as toothpastes, mouthrinses, liquid dentifrices, lozenges and gums containing at least one phosphate derivative and a copper source.

Description

ORAL COMPOSITIONS
TECHNICAL FIELD The present invention relates to oral compositions which provide antiplaque and antigingivitis benefits as well as being effective against other anaerobic infections of the mouth.
BACKGROUND OF THE INVENTION Plaque induced diseases, including periodontitis and gingivitis, are believed to involve anaerobic bacterial infections. Periodontal disease affects the periodontium, which is the investing and supporting tissue surrounding a tooth (i.e., the periodontal ligament, the gingiva, and the alveolar bone). Gingivitis and periodontitis are in¬ flammatory disorders of the gingiva and the periodontal ligament, respectively. Gingivosis and periodontosis are more severe conditions involving degenerative disorders of the tissue. Combinations of inflammatory and degenerative conditions are termed periodontitis complex.
Periodontal disease is a major cause of tooth loss in adults. Tooth loss from periodontal disease is a significant problem beginning at age 35, but even by age 15 it is estimated that about 4 out of 5 persons already have gingivitis and 4 out of 10 have periodontitis.
While good oral hygiene, as achieved by brushing the teeth with a cleansing dentifrice, may help reduce the incidence of periodontal disease, it does not necessar¬ ily prevent or eliminate its occurrence. This is because microorganisms contribute to both the initiation and progress of periodontal disease. Thus, in order to prevent or treat periodontal disease, these microorganisms must be suppressed by some means other than simple mechanical scrubbing. Towards this end, there has been a great deal of research aimed at developing therapeutic dentifrices, mouthwashes, and methods of treating periodontal disease which are effective in suppressing these microorganisms. The use of copper compounds in oral products have been widely published.
One such reference, U.S. Patent 4.332.791. issued June 1, 1982 to Raaf et al., describes combinations containing copper salts in dentifrice compositions employing a silica abrasive. Similar references include U.S. Patent 4.652.444. issued March 14, 1987, to Maurer and U.S. Patent Application Serial Number 08/096,535 to Mobley et al., filed July 22, 1993, each further describing the use of copper compounds in oral care products.
An important disadvantage of these compounds, however, relates to the unpleasant aftertaste associated with their oral use. The importance of such a disadvantage becomes apparent when viewed in light of consumer satisfaction. Products with poor flavor, or unpleasant after-tastes may limit consumer satisfaction and, eventually, consumer usage. The present inventors have discovered that the compositions of the present invention which contain copper compounds along with certain phosphate derivatives, provide improved tasting, antiplaque/antigingivitis compositions. Additionally, the present inventors have found that incorporating such phosphate derivatives provides improved actual and/or perceived efficacy of the resultant compositions. Further, these phosphate derivatives result in oral compositions providing a delayed flavor onset.
It is therefore an object of the present invention is to provide improved copper containing, oral compositions comprising a combination of phosphate derivatives.
Another object of the present invention is to provide good-tasting oral com- positions effective in preventing and treating diseases of the oral cavity and prevent¬ ing mouth odor.
A further object of the present invention is to provide methods for preventing and treating diseases of the oral cavity.
These and other objects will become readily apparent from the disclosure which follows.
All percentages and ratios used herein are by weight unless otherwise speci¬ fied. Also, all measurements referred to herein are made at 25 °C in the composition unless otherwise specified.
SUMMARY OF THE INVENTION The present invention relates to oral compositions, comprising. a) from about 0.001% to about 25% of at least one phosphate derivative having the structure:
Figure imgf000004_0001
wherein R is selected from the group consisting of a coolant compo¬ nent, a sweetener component, and a flavorant component; wherein R' and R" are independently selected from the group consist¬ ing of R, an adherent component, M+, M"1" ", C+, and hydrogen; wherein X, X', X" are independently selected from the group consist¬ ing of oxygen, nitrogen, and sulfur; wherein n is an integer from 1 to 3; b) a safe and effective amount of a copper ion source; and c) a pharmaceutically acceptable oral carrier. The present invention also relates to the above compositions further compris¬ ing a flavoring agent.
The present invention further relates to methods of treating or preventing diseases of the oral cavity.
By "oral composition," as used herein, means a product which in the ordinary course of usage is not intentionally swallowed for purposes of systemic administra¬ tion of particular therapeutic agents, but is rather retained in the oral cavity for a time sufficient to contact substantially all of the dental surfaces and/or oral tissues for purposes of oral activity.
By "safe and effective amount" as used herein means sufficient amount of material to provide the desired benefit while being safe to the hard and soft tissues of the oral cavity.
By the term "pharmaceutically acceptable oral carrier," as used herein, means a suitable vehicle which can be used to apply the present compositions to the oral cavity in a safe and effective manner. All levels and ratios are by weight of the total composition, unless otherwise indicated. Additionally, all measurements are made at 25°C unless otherwise speci¬ fied.
DETAILED DESCRIPTION OF THE INVENTION The essential as well as optional components of the compositions of the pre- sent invention are described in the following paragraphs.
ESSENTIAL COMPONENTS Phosphate Derivatives
The compositions of the present invention contain one or more phosphate derivatives. These compounds may be formulated by phosphorylating at least one coolant, sweetener or flavorant component. These compounds also include linking at least one coolant, sweetener or flavorant component to an adherent component via a phosphate bridge. In addition, pyrophosphate and triphosphate groupings may be substituted for the phosphate group. Coolant, flavorant, or adherent components may also be linked to phosphorous via two functional groups or attachment sites. Furthermore, the phosphate derivatives described above may be bound via Coulom- bic interaction with charged compounds or materials, including polymers The present compositions may deliver the desired coolant, flavorant and/or sweetener qualities through the action of the phosphate derivative itself. The com¬ positions may also provide a sustained or delayed effect since release of the coolant, flavorant and/or sweetener component from the molecule does not occur until cleavage of the phosphate from the coolant, flavorant and/or sweetener by phosph- atase enzymes. Without being limited by theory, it is believed that this sustained or delayed release profile provides improved actual and/or perceived efficacy. The phosphatase enzymes may include, but are not limited to, acidic, basic, or pyro- phosphatases.
The term "coolant component" as used herein refers to coolant compounds having a hydroxy, amino, or thiol functionality which is capable of forming an ester, amido, or thioester linkage with a phosphorus(V) atom. Preferred coolant compo¬ nents are selected from the group consisting of menthol, 3-l-menthoxypropane-l,2- diol (TK-10 supplied by Takasago Perfumery Co., Ltd., Tokyo, Japan), menthone glycerol acetal ("MGA"), N-ethyl-p-menthane-3-carboxamide (WS-3 supplied by Sterling Organics), N,2,3-trimethyl-2-isopropylbutanamide (WS-23 supplied by SCM Glidco Organics) or menthyl lactate. While the terms "menthol" and "menthyl" as used herein can include the dextro- or levo-rotatory isomers of these compounds or racemic mixtures thereof, the preferred embodiments of the present invention incor¬ porate the levorotatory isomers. The term "flavorant component" as used herein refers to flavorant chemicals having a hydroxy, amino, or thiol functionality which is capable of forming either an ester, amido, or thioester linkage with a phosphorus(V) atom. Flavorant chemicals suitable for use in the present invention include hexanol, octanol, decanol, geranolol, ethyl maltol, para-hydroxy phenylbutanone, phenyl ethyl alcohol, thymol, eugenol, eucalyptol, methyl salicylate, ethyl vanillin, vanillin, cinnamaldehyde glycerol acetal ("CGA"), or linalool. Further examples of suitable chemical flavorants are described in S. Arctander, Perfume and Flavor Chemicals. (1969) and Allure Publishing Corpo¬ ration's Flavor and Fragrance Materials. (1993), both of which are herein incorpo¬ rated by reference. The term "sweetener component" as used herein refers to sweetener com¬ pounds having a hydroxy, amino, or thiol functionality which is capable of forming either an ester, amido, or thioester linkage with a phosphorus(V) atom. Preferred -sweetener components are saccharin, xylitol, mannitol, sorbitol, acesulfame K, aspartame, and neohesperidin dihydrochalcone
The term "adherent component" as used herein refers to either monomers, oligomers, or polymers having hydroxy, amino, or thiol functionalities which are capable of forming either ester amido, or thioester linkages with phosphorus(V) atoms. The monomers, oligomers, or polymers may also possess additional hydroxy, amino, or thiol groups which may either remain unsubstituted or be linked via ester amido, or thioester linkages to a phosphorus(V) atom which is also attached to a coolant, flavor, or active portion. Preferred compounds are selected from the group consisting of C12-C18 diacyl glycerol, partially hydrolyzed vinyl acetate/ethylene copolymer, cellulose, chitin, glucosamine, silica gel, glycerol, and lower alkyl vinyl ether-maleic acids.
The terms "M+" and "M++" as used herein refer to physiologically relevant metal cations. The phrase "physiologically relevant metal cations" as used herein refers to metal cations that are significant to the organic or bodily processes of a human or lower animal. Preferred "M+" cations are sodium and potassium. Pre¬ ferred "M++" cations are calcium, zinc, magnesium, manganese, copper, and stan- nous.
The term "C+" as used herein refers to a cation. A cation as used herein refers to cations that contain positively charged nitrogen, phosphorus, oxygen, or sul¬ fur atoms. Such cations may contain more than one positively-charged site and in the case of oligomers or polymers containing nitrogen, phosphorus, oxygen, or sulfur at¬ oms, many positively-charged centers may exist. Preferred cations include ammo¬ nium, protonated amines such as protonated glucosamine, and partially or fully protonated amine-containing polymers such as protonated chitosan.
The phosphate derivatives of this invention are represented by the following formula.
0
Figure imgf000007_0001
In the above formula, R is selected from the group consisting of a coolant component, a sweetener component, and a flavorant component;
R' and R" are independently selected from the group consisting of R, an adherent component, M+, M++, C+, and hydrogen;
X, X", and X" are independently selected from the group consisting of oxy¬ gen, nitrogen, and sulfur; and n is an integer from 1 to 3.
In addition, R' may equal R", preferably wherein R' and R" are selected from the group consisting of calcium, zinc, magnesium, manganese, copper and stannous.
Preferred phosphate derivatives have the formula:
0
Figure imgf000008_0001
R" In the above formula:
R is selected from the group consisting of menthol, TK-10, WS-3, WS-23, MGA, methyl salicylate, acesulfame K, aspartame, saccharin, mannitol, sorbitol, neohesperidin dihydrochalcone, eugenol, vanillin, thymol, CGA, and linalool;
R' and R" are independently selected from the group consisting of R, C12- C 18 diacyl glycerol, partially hydrolyzed vinyl acetate-ethylene co-polymer, cellulose, chitin, glucosamine, silica gel, glycerol, lower alkyl vinyl ether-maleic acids, sodium, potassium, calcium, zinc, magnesium, manganese, copper and stannous, ammonium, protonated amines, partially or fully protonated amine-containing polymers, and hydrogen;
X, X', and X" are independently selected from the group consisting of oxy¬ gen, nitrogen, and sulfur; and n is and integer from 1 to 3.
In addition, R' may equal R", preferably wherein R' and R" are independently selected from the group consisting of calcium, zinc, magnesium, manganese, copper and stannous.
Most preferred phosphate derivatives are menthyl monophosphate, eugenyl monophosphate, thymyl monophosphate, vanillyl monophosphate. The phosphate derivatives are used in the present invention at levels of from about 0.001% to about 25%, preferably from about 0.01% to about 15%, and most preferably from about 0.10% to about 5% by weight of the composition. Mixtures of the above described phosphate derivatives may also be used, improving the phosphate derivative activity. Copper ion source
Another essential component of the present invention is a compound providing a readily available source of copper ions. Compounds useful as such a copper ion source may be present in the compositions of the present invention at levels between about 1 and about 8000 ppm of copper ions. The preferred range being from about 25 to about 6000 ppm, with the most preferred range being from about 50 to about 4000 ppm. For dentifrices the preferred levels are from about 50 to about 8000 ppm, more preferably from about 100 to about 6000 ppm, and most preferably from about 100 to about 4000 ppm. For rinses the levels are preferably from about 25 to about 1000 ppm, more preferably from about 50 to about 750 ppm, and most preferably from about 50 to about 500 ppm. For lozenges and chewing gums levels as low as about 1 ppm copper are effective.
Suitable inorganic copper ion sources include copper chloride, CuCl , and the dihydrate thereof; copper fluoride, CuF and the dihydrate thereof; copper fluorosili- cate, CuSiF , and the hexahydrate thereof; copper sulphate, CuSO , and the pen- 6 4 tahydrate thereof; copper nitrate and the tri- and hexa-hydrates thereof; and also less popular copper salts, such as copper bromide, CuBr ; copper metaborate,
Cu(BO ) ; copper bromate, Cu(BrO ) ; copper chlorate; Cu(ClO ) 6-H O; copper lodate, Cu(IO ) , copper fluorophosphate, CuPO F, or mixtures thereof.
Preferred copper salts of organic acids include copper acetate, copper for- miate, copper benzoate, copper citrate, copper tartrate, copper lactate, copper malate, copper lysinate, copper mandelate, copper sorbate, copper pantothenate, copper gluconate, copper phytate, copper glycerophosphate, copper cinnamate, copper butyrate, copper propionate, copper laurate, copper oxalate, copper salicy¬ late, copper glycinate, copper bis-glycinate or mixtures thereof. Mixtures of inor- ganic or organic salts may also be used.
A preferred copper ion source for the compositions of the present invention is copper bis-glycinate. Copper bis-glycinate is further described in U.S. Patent Appli¬ cation Serial Number 08/096,535 to Mobley et al., filed July 22, 1993, herein incor¬ porated by reference. Pharmaceutically Acceptable Carrier
The carrier for the active ingredient(s) herein can be any composition suitable for use in the oral cavity. Such compositions include toothpastes, mouthrinses, liquid dentifrices, lozenges, chewing gums or other vehicles suitable for use in the oral cavity. Toothpaste and mouthrinses are the preferred systems.
The abrasive polishing material contemplated for use in the toothpaste com¬ positions of the present invention can be any material which does not excessively abrade dentin. These include, for example, silicas including gels and precipitates, calcium carbonate, dicalcium orthophosphate dihydrate, calcium pyrophosphate, tricalcium phosphate, calcium polymetaphosphate, insoluble sodium polymetaphos- phate, hydrated alumina, and resinous abrasive materials such as particulate conden¬ sation products of urea and formaldehyde, and others such as disclosed by Cooley et al. in U.S. Patent 3.070.510. December 25, 1962, incoφorated herein by reference. Mixtures of abrasives may also be used.
Silica dental abrasives, of various types, can provide the unique benefits of exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentin. For these reasons they are preferred for use herein. The silica abrasive polishing materials useful herein, as well as the other abra¬ sives, generally have an average particle size ranging between about 0.1 and 30 microns, preferably 5 and 15 microns. The silica abrasive can be precipitated silica or silica gels such as the silica xerogels described in Pader et al., U.S. Patent 3.538.230. issued March 2, 1970 and DiGiulio, U.S. Patent 3.862.307. June 21, 1975, both incoφorated herein by reference. Preferred are the silica xerogels marketed under the tradename "Syloid" by W. R. Grace & Company, Davison Chemical Division. Preferred precipitated silica materials include those marketed by the J. M. Huber Coφoration under the tradename, "Zeodent", particularly the silicas carrying the designation "Zeodent 119" and "Zeodent 128". A further description of silica abra- sives suitable for use in the present invention are found in U.S. Patent 4.340.583. July 29, 1982, incoφorated herein by reference.
The abrasive in the toothpaste compositions described herein is present at a level of from about 6% to 70%, preferably from about 15% to about 25%.
Flavoring agents can also be added to toothpaste compositions. Suitable fla- voring agents include oil of wintergreen, oil of peppermint, oil of spearmint, oil of cloves or mixtures thereof. Additional flavoring agents useful in the compositions of the present invention apart from those mentioned as components of the phosphate derivatives include anise, cassia, anethole, dihydroanethole, ethyl maltol, estragole, menthol, para-hydroxy phenylbutanone, phenyl ethyl alcohol, sweet birch, thymol, eugenol, eucalyptol, cinnamic aldehyde, menthone, alpha-ionone, ethyl vanillin, vanillin, limonene, isoamylacetate, benzaldehyde, ethylbutyrate, cinnamaldehyde glycerol acetal ("CGA"), linalool, 1-carvone, and mixtures thereof. Further examples of suitable flavoring agents are described in S. Arctander, Perfume and Flavor Materials of Natural Origin. (1960), herein incoφorated by reference, and in the above mentioned Allure's Flavor and Fragrance Materials. Sweetening agents which can be used include aspartame. acesulfame K, saccharin, dextrose, levulose, xylitol, mannitol and sodium cyclamate. Flavoring and sweetening agents are generally used in toothpastes at levels of from about 0.005% to about 2% by weight.
Toothpaste compositions can also contain emulsifying agents. Suitable emulsi¬ fying agents are those which are reasonably stable and foam at a wide pH range, including non-soap anionic, nonionic, cationic, zwitterionic and amphoteric organic synthetic detergents. Many of these suitable agents are disclosed by Gieske et al. in U.S. Patent 4.051.234. September 27, 1977, incoφorated herein by reference. The emulsifying agents are present at a level of from about 0.5% to about 10.0%.
Water is also present in the toothpastes of this invention. Water employed in the preparation of commercially suitable toothpastes should preferably be deionized and free of organic impurities. Water generally comprises from about 10% to 50%, preferably from about 30% to 50%, by weight of the toothpaste compositions herein. These amounts of water include the free water which is added plus that which is introduced with other materials such as with sorbitol.
In preparing toothpastes, it is necessary to add some thickening material to provide a desirable consistency. Preferred thickening agents are carboxyvinyl polymers, carrageenan, hydroxyethyl cellulose and water soluble salts of cellulose ethers such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxy¬ ethyl cellulose. Natural gums such as gum karaya, xanthan gum, gum arabic, and gum tragacanth can also be used. Colloidal magnesium aluminum silicate or finely divided silica can be used as part of the thickening agent to further improve texture. Thickening agents in an amount from 0.2% to 5.0% by weight of the total composi¬ tion can be used.
It is also desirable to include some humectant material in a toothpaste to keep it from hardening. Suitable humectants include glycerin, sorbitol, and other edible polyhydric alcohols at a level of from about 10% to about 70%.
Another preferred embodiment of the present invention is a mouthwash com¬ position. Conventional mouthwash composition components can comprise the carrier for the agents of the present invention. Mouthwashes generally comprise from about 20: 1 to about 2: 1 of a water/ethyl alcohol solution or be alcohol free and, preferably, other ingredients such as flavors, sweeteners, humectants and sudsing agents such as those mentioned above for dentifrices. The humectants, such as glycerin and sorbitol give a moist feel to the mouth. Generally, on a weight basis the mouthwashes of the invention comprise 0% to 30% (preferably 0% to 5%) ethyl alcohol, 0% to 30% (preferably 5% to 30%) of a hu ectant, 0% to 2% (preferably 0.01% to 1.0%) emulsifying agents, 0% to 0.5% (preferably 0.005% to 0.10%) sweetening agent such as saccharin, 0% to 0.6% (preferably 0.03% to 0.3%) flavor- ing agent, and the balance water. Other optional components described herein earlier for use in toothpaste products are also useful in the mouthwash composition.
Suitable lozenge and chewing gum components are disclosed in U.S. Patent 4.083.955. April 11, 1978 to Grabenstetter, incoφorated herein by reference in its entirety. An additional optional ingredient for use in the compositions of the present invention is a soluble fluoride ion source. Such sources include sodium fluoride, stannous fluoride, sodium monofluorophosphate and are used in amounts sufficient to provide from about 10 to about 3500 ppm F .
Other optional components are non-cationic water insoluble agents such as triclosan. Such materials are disclosed in U. S. 4.022.889. to Vinson et al., incoφo¬ rated herein by reference in its entirety.
The pH of the present compositions and/or the pH in the mouth can be any pH which is safe for the mouth's hard and soft tissues. Such pH*s are generally from about 4.0 to about 9.5, preferably from about 4.5 to about 8.5. Buffers may be added to maintain this pH. Such buffers should, however, not complex with copper ions in a manner such that the functioning of the compositions of this invention is hindered.
A method of manufacture for the present compositions is found in the exam¬ ples. COMPOSITION USE
The present compositions are used in a conventional manner wherein the amounts of product are what users generally use.
The following examples further describe and demonstrate preferred embodi¬ ments within the scope of the present invention. The examples are given solely for illustration and are not to be construed as limitations of this invention as many variations thereof are possible without departing from the spirit and scope thereof.
EXAMPLES EXAMPLES 1-5 Given below are five mouthrinse examples representative of the present invention. Component Weigh t %
Ex. 1 Ex. 2 Ex. 3 Ex . 4 E 5
Water 70.86 87.41 69.15 62.38 73.13
Sorbitol Solution (70% Aqueous) 10.25 — — 8.85 7.25
Sodium Saccharin 0.08 0.07 0.06 0.08 0.07
Ethyl Alcohol 10.60 — 18.74 14.48 12.20
PEG 40 hydrogenated caster oil * 0.46 0.75 — 0.34 0.57
Sodium Alkyl Sulfate Soln (27.9%) 0.75 0.75 0.60 0.60 0.75
Copper Sulfate 0.05 0.10 0.10 0.20 0.05
Glycine 0.03 0.06 0.06 0.12 0.03
Peppermint Flavor 0.24 0.20 0.19 0.16 0.20
Glycerin 6.18 10.26 10.45 12.35 5.37
Eugenyl Monophosphate 0.15 — — 0.32 —
Vanillyl Monophosphate 0.35 — — — 0.38
Thymyl Monophosphate — 0.40 0.20 0.12 —
Menthyl Monophosphate — — 0.45 — —
1 Available from BASF-Wyandotte, Parsippany, N.J. under the tradename Cremophor RH40.
EXAMPLES 6-10 Given below are five dentifrice examples representative of the present inven¬ tion.
Component Weight %
Ex. 6 Ex. 7 Ex. 8 Ex. 9 Ex. 10
Water 7.82 17.14 8.02 4.38 14.79
Sorbitol Solution (70% Aqueous) 54.27 46.86 52.45 58.48 47.25
Sodium Saccharin 0.37 0.40 0.30 0.38 0.35
Sodium Fluoride 0.24 0.24 0.24 0.24 0.24
Carboxy Methyl Cellulose 1.00 0.75 1.10 0.95 1.07
Sodium Alkyl Sulfate Soln (27.9%) 4.20 3.85 5.30 3.45 3.75
Titanium Dioxide 0.53 0.53 0.53 0.53 0.53
Silica 23.00 22.50 23.40 22.40 22.50
Sodium Hydroxide (50% Soln.) 0.22 0.22 0.10 0.10 0.22
Copper Sulfate 0.41 0.41 0.21 0.21 0.41
Glycine 0.24 0.24 0.12 0.12 0.24
Peppermint Flavor 1.20 1.10 1.05 1.16 1.20
Glycerin 5.30 4.86 5.68 6.25 3.95 Eugenyl Monophosphate 0.35 — — 1.35 1.20
Vanillyl Monophosphate 0.85 — 1.00 0.80
Thymyl Monophosphate — 0.90 —
Menthyl Monophosphate — — 0.50 1.50
Component Weight %
Ex. 11 Ex. 12
Water 7.82 17.84
Sorbitol Solution (70% Aqueous) 54.27 46.86
Sodium Saccharin 0.37 0.40
Sodium Fluoride 0.24 0.24
Carboxy Methyl Cellulose 1.00 0.75
Sodium Alkyl Sulfate Soln (27.9%) 4.20 3.85
Titanium Dioxide 0.53 0.53
Silica 23.00 22.50
Sodium Hydroxide (50% Soln.) 0.22 0.22
Copper Sulfate 0.41 0.41
Glycine 0.24 0.24
Peppermint Flavor 1.20 1.10
Glycerin 5.30 4.86
Menthyl Monophosphate 1.20 —
Saccharin Monophosphate — 0.20
WHAT IS CLAIMED IS:

Claims

What is Claimed is:
1. An oral composition, comprising: a) from 0.001% to 25% of at least one phosphate derivative having the structure:
Figure imgf000015_0001
R" wherein R is selected from the group consisting of a coolant compo¬ nent, a sweetener component, and a flavorant component, wherein R' and R" are independently selected from the group consist¬ ing of R, an adherent component, M"1", M"*-1", C+, and hydrogen; wherein X, X', X" are independently selected from the group consist¬ ing of oxygen, nitrogen, and sulfur, the phosphate derivative, preferably selected from the group consisting of eugenyl monophosphate, vanillyl monophosphate, thymyl monophosphate, menthyl monophosphate and mixtures thereof, most preferably comprising eugenyl monophosphate and vanillyl monophosphate; wherein n is an integer from 1 to 3; b) a safe and effective amount of a copper ion source, preferably providing from 1 to 8000 parts per million copper ions and more preferably selected from the group consisting of copper bis-glycinate, copper gluconate and mixtures thereof; and c) a pharmaceutically acceptable oral carrier, preferably a liquid dentifrice carrier, more preferably a mouthwash carrier, most preferably a toothpaste carrier.
An oral composition according to Claim 1, further comprising a flavoring agent selected from the group consisting of anise, cassia, clove, anethole, di- hydroanethole, estragole, menthol, peppermint, para-hydroxy phenylbu- tanone, ethyl maltol, phenyl ethyl alcohol, sweet birch, thymol, eugenol, eucalyptol, wintergreen, spearmint, cinnamic aldehyde, menthone, al- pha-ionone, ethyl vanillin, vanillin, limonene, isoamylacetate, benzaldehyde, ethylbutyrate, cinnamaldehyde glycerol acetal ("CGA"), linalool, 1-carvone, and mixtures thereof.
3. An oral composition according to any one of the preceding Claims, further comprising a cooling agent selected from the group consisting of : 3-1- menthoxypropane 1,2-diol, N-ethyl-p-menthane-3-carboxamide, N,2,3- trimethyl-2-isopropylbutanamide and mixtures thereof.
4. An oral composition according to any one of the preceding Claims, further comprising a dentally acceptable abrasive, preferably a silica abrasive.
5. An oral composition according to any one of the preceding Claims, further comprising a fluoride ion source, preferably sodium fluoride.
6. An oral composition according to any one of the preceding Claims, further comprising a humectant.
7. An oral composition according to any one of the preceding Claims, further comprising from 0 to 30% ethanol.
8. An oral composition according to any one of the preceding Claims, wherein the orally acceptable carrier is a lozenge or a chewing gum.
PCT/US1995/014013 1994-11-18 1995-10-27 Oral compositions WO1996015768A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU40160/95A AU4016095A (en) 1994-11-18 1995-10-27 Oral compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34171694A 1994-11-18 1994-11-18
US08/341,716 1994-11-18

Publications (1)

Publication Number Publication Date
WO1996015768A1 true WO1996015768A1 (en) 1996-05-30

Family

ID=23338719

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/014013 WO1996015768A1 (en) 1994-11-18 1995-10-27 Oral compositions

Country Status (5)

Country Link
US (1) US5628986A (en)
AU (1) AU4016095A (en)
PE (1) PE52096A1 (en)
TR (1) TR199501447A2 (en)
WO (1) WO1996015768A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002273A1 (en) * 1995-07-05 1997-01-23 The Procter & Gamble Company Warming compounds
WO1998023250A1 (en) * 1996-11-26 1998-06-04 The Procter & Gamble Company Flavor systems for oral care products
US5885554A (en) * 1997-01-10 1999-03-23 The Procter & Gamble Company Hydrophobic agents and polymeric surfactants
EP0967883A1 (en) * 1996-11-27 2000-01-05 Wm. Wrigley Jr. Company Chewing gum composition containing sodium glycinate

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2143037C (en) * 1994-05-02 2002-04-30 Atma Chaudhari Alcohol free mouthwash
WO1997028782A1 (en) * 1996-02-08 1997-08-14 Warner-Lambert Company Anticalculus dentifrice containing highly soluble pyrophosphate
US5837286A (en) * 1997-01-15 1998-11-17 Pandya; Harish B. Taste masking for unplatable formulations
US5888479A (en) * 1997-12-31 1999-03-30 Carlin; Edward J. Method for deterring smoking
JP2003517442A (en) * 1998-09-23 2003-05-27 ユニリーバー・ナームローゼ・ベンノートシヤープ Oral care composition
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US6491540B1 (en) * 1999-09-20 2002-12-10 Jack Barreca Center-filled supplement gum
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US6315987B1 (en) * 2000-05-10 2001-11-13 Isp Investments Inc. Polymeric delivery and release systems for oral care actives
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6306372B1 (en) * 2000-06-21 2001-10-23 Noville Inc. Oral hygiene compositions which mask the burn sensation and the astringency of eucalyptol and zinc
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6379652B1 (en) * 2000-10-16 2002-04-30 Colgate Palmolive Company Oral compositions for reducing mouth odors
US6582682B2 (en) * 2000-10-30 2003-06-24 Noville, Inc. Oral care compositions comprising stabilized chlorine dioxide
US6494716B1 (en) * 2000-11-27 2002-12-17 Alma Dorn Dental etch with improved flavor
JP3497466B2 (en) * 2000-12-12 2004-02-16 高砂香料工業株式会社 Warming composition
JP4454838B2 (en) * 2000-12-12 2010-04-21 高砂香料工業株式会社 Warm composition
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
US6916463B2 (en) * 2002-09-24 2005-07-12 The Procter & Gamble Company Oral products having an aesthetic layer
EP1682079B1 (en) * 2003-11-12 2007-04-25 Symrise GmbH & Co. KG Mixture with wintergreen odor and flavor
KR100725581B1 (en) 2004-06-29 2007-06-08 주식회사 동부하이텍 Thymol, carvacrol and their derivatives having phytopathogenic fungi activities
WO2008042944A2 (en) * 2006-10-05 2008-04-10 The Trustees Of Columbia University In The City Of New York Non-irritating oral care formulations
MX349338B (en) * 2010-10-01 2017-07-21 The Procter & Gamble Company * Oral care compositions with improved flavor.
CN104983595A (en) * 2015-06-27 2015-10-21 合肥九研医药科技开发有限公司 Mouth wash and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512599A2 (en) * 1991-05-09 1992-11-11 Unilever N.V. Phosphorylated polyhydroxy compounds for tartar control
US5244651A (en) * 1991-09-04 1993-09-14 Kao Corporation Method of desensitizing hypersensitive dentin
WO1994026243A1 (en) * 1993-05-13 1994-11-24 The Procter & Gamble Company Oral compositions
WO1995007683A1 (en) * 1993-09-17 1995-03-23 The Procter & Gamble Company Composition containing phosphate derivatives

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE290352C (en) *
US3780190A (en) * 1971-05-03 1973-12-18 American Sweetener Corp Artificial sweetening composition
US4045290A (en) * 1975-02-28 1977-08-30 Princeton Biomedix Incorporated Diagnostic method and compounds for use therewith
JPS5927B2 (en) * 1976-08-06 1984-01-05 武田薬品工業株式会社 Frozen food manufacturing method
JPS553741A (en) * 1978-06-21 1980-01-11 Ajinomoto Co Inc Novel composite seasoning
JPS58129958A (en) * 1982-01-29 1983-08-03 Koasa Shoji Kk Method for improving taste of laver product
US4472447A (en) * 1982-06-22 1984-09-18 Ajinomoto Co., Inc. Mixed seasoning on basis of monosodium glutamate
BE902690A (en) * 1985-06-18 1985-10-16 Cederroth Nordic Ab Compsn. contg. sodium, potassium and magnesium salts - including carboxylate(s) and/or phosphonate(s), as substitute for sodium chloride in foodstuff or as table salt
US4826824A (en) * 1985-10-25 1989-05-02 Duke University Method of enhancing the taste perception of sweetness of aspartame and derivatives thereof
JPS63157545A (en) * 1986-12-22 1988-06-30 Nippon Telegr & Teleph Corp <Ntt> Interdevice communication system
CH670743A5 (en) * 1987-04-06 1989-07-14 Nestle Sa
US5216945A (en) * 1987-04-06 1993-06-08 Nestec S.A. Apparatus for preparation of a flavoring agent
JPH01115557A (en) * 1987-10-28 1989-05-08 Ricoh Co Ltd Method for working metal die for molding lens
JPH01222755A (en) * 1988-03-02 1989-09-06 T Hasegawa Co Ltd Seasoning
KR930000842B1 (en) * 1990-11-28 1993-02-06 포항종합제철주식회사 Process for making high oxygen rimmed steel
US5260051A (en) * 1990-12-17 1993-11-09 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising phosphate ester compounds containing a beneficial reagent component
JPH04346748A (en) * 1991-05-21 1992-12-02 Kao Corp Baked cake
US5374418A (en) * 1992-02-13 1994-12-20 Kao Corporation Composition for use in oral cavity
AU3797593A (en) * 1992-03-20 1993-10-21 Procter & Gamble Company, The Oral care compositions comprising certain substituted diphenyl ethers
US5370865A (en) * 1992-05-15 1994-12-06 Kao Corporation Composition for use in oral cavity
RO117061B1 (en) * 1992-07-10 2001-10-30 Novatech Inc Nashville Composition for enhancing food flavour and preparation process
EP0719129A1 (en) * 1993-09-17 1996-07-03 The Procter & Gamble Company Pyrophosphate diesters for tartar control
US5472672A (en) * 1993-10-22 1995-12-05 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for polymer synthesis using arrays

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512599A2 (en) * 1991-05-09 1992-11-11 Unilever N.V. Phosphorylated polyhydroxy compounds for tartar control
US5244651A (en) * 1991-09-04 1993-09-14 Kao Corporation Method of desensitizing hypersensitive dentin
WO1994026243A1 (en) * 1993-05-13 1994-11-24 The Procter & Gamble Company Oral compositions
WO1995007683A1 (en) * 1993-09-17 1995-03-23 The Procter & Gamble Company Composition containing phosphate derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997002273A1 (en) * 1995-07-05 1997-01-23 The Procter & Gamble Company Warming compounds
WO1998023250A1 (en) * 1996-11-26 1998-06-04 The Procter & Gamble Company Flavor systems for oral care products
EP0967883A1 (en) * 1996-11-27 2000-01-05 Wm. Wrigley Jr. Company Chewing gum composition containing sodium glycinate
EP0967883A4 (en) * 1996-11-27 2000-04-05 Wrigley W M Jun Co Chewing gum composition containing sodium glycinate
US5885554A (en) * 1997-01-10 1999-03-23 The Procter & Gamble Company Hydrophobic agents and polymeric surfactants

Also Published As

Publication number Publication date
US5628986A (en) 1997-05-13
TR199501447A2 (en) 1996-06-21
PE52096A1 (en) 1996-12-09
AU4016095A (en) 1996-06-17

Similar Documents

Publication Publication Date Title
US5628986A (en) Oral compositions
EP2934446B1 (en) Oral care products comprising zinc oxide and trimethylglycine
US4902498A (en) Oral compositions
EP3100716B1 (en) Novel salts and their uses
US5389360A (en) Oral compositions
EP0782437B1 (en) Oral compositions
KR20150092759A (en) Zinc phosphate containing compositions
KR20150092255A (en) Fluoride-stable zinc containing oral care compositions
EP2046270A2 (en) High fluoride ion oral care composition and method for maintaining anticaries activity
EP0626843A1 (en) Use of polyvinyl pyrrolidone for reducing the adherence of oral bacteria.
JPH07509486A (en) Oral composition
EP3368163B1 (en) Mouthwash products and methods
CA2711263A1 (en) Compositions and methods for the treatment of xerostomia
EP0089136A2 (en) Oral hygiene products
JPH02286613A (en) New composition
JPH11510161A (en) Oral composition
AU2016367080B2 (en) Metal amino acid complexes for bacterial aggregation
JPH10501265A (en) Mouth rinse composition
US5496539A (en) Oral compositions
AU2022283266A1 (en) Oral care compositions
JP2001172146A (en) Composition for oral cavity
CA3149613A1 (en) Zinc phosphate containing compositions
WO2023076406A1 (en) Oral care compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AU BB BG BR BY CA CN CZ EE FI GE HU IS JP KG KP KR KZ LK LR LT LV MD MG MK MN MX NO NZ PL RO RU SG SI SK TJ TM TT UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA